Abstract: Objective： To promote modernization of traditional Chinese medicine in China， and to understand current situation of traditional Chinese medicine， trying to build an innovative management model suitable for the inheritance and development of Chinese traditional medicine. Methods：Based on the background that traditional Chinese medicine business has been strongly supported by the government， this study analyzed the data through domestic traditional Chinese medicine database of 2009—2014 provided by the CFDA Information Center and explored current situation of domestic traditional Chinese medicine. This study systematically analyzed the distribution of Chinese traditional medicine in dosage form， treatment area， and identified core manufactures of traditional Chinese medicine by combining approval of protection of traditional Chinese medicine. Results： The development of Chinese medicine had a phenomenon of homogeneity. The treatment of traditional Chinese medicine injections did not show advantages and the development of traditional Chinese medicine manufactures was unilateral. Conclusion： It is suggested to construct an innovative examination and approval model for traditional Chinese medicine. Traditional Chinese medicine injection should focus on treatment of acute and severe diseases， both large and small manufactures should be developed in coordination.